一体化治疗对慢性肾病患者的临床疗效观察

Clinical efficacy of integrated treatmeut in patieut with chronic kidney otisease

目的:观察一体化治疗对慢性肾病的临床治疗效果。方法:选择2010~2012年来我院进行首次血液透析的终末期肾病患者125例分为二组,A组为在进行血液透析前未进行一体化治疗,B组患者透析前进行了一体化治疗,观察CO2CP,Scr,Ccr,Hb,Alb,血P、血Ca,收缩压和舒张压变化,及透析时并发症发生情况。结果:A组患者在营养治疗,肾性贫血的纠正,监测甲状旁腺激素及调节钙磷平衡,血压控制等方面均不如B组患者(P【0.05);与B组比较,A组患者的贫血、代谢性酸中毒、钙磷代谢紊乱、低白蛋白血症明显,急诊透析多,血压控制不理想(P【0.05)。结论:通过对慢性肾脏病患者一体化治疗的管理,患者延缓进入透析的时间且并发症明显减少,替代治疗的血管通路充分,患者生存率和生活质量得以提高。

Objective To observe the integrated treatment of clinical treatment of chronic kidney disease. Methods 2010 to 2012 to our hospital for the first time on hemodialysis ESRD patients 125 were divided into two groups, A group integration during hemodialysis treatment, patients in group B integrated pre-dialysis treatment , observed CO2CP, Scr, Ccr, Hb, Alb, blood P, blood Ca, systolic and diastolic blood pressure, and dialysis compli-cations. Results A group of patients in nutritional therapy, renal anemia corrected, parathyroid hormone monitor-ing and regulation of calcium and phosphorus balance, blood pressure control are not as good as the patients in group B (P<0.05);compared with group B, patients in group A anemia, metabolic acidosis, calcium and phospho-rus metabolism, hypoalbuminemia, emergency dialysis, blood pressure control (P<0.05). Conclusion Through the the management integrated treatment of chronic kidney disease patients delay the time to dialysis and reduce complications, full replacement therapy vascular access, patient survival and quality of life can be improved.